A collaborative experimental study led by researchers at Cima and Clinica Universidad de Navarra proposes a new therapeutic approach against cancer that dissociates efficacy and toxicity in the use of combined immunotherapy ...
May 3, 2019
0
197
Oncologists at the Fred Hutchinson Cancer Research Center have successfully treated a patient with metastatic melanoma by combining two different types of immunotherapy. Cassian Yee and colleagues describe their approach ...
May 30, 2016
0
25
Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers from The University of Texas MD Anderson Cancer Center showed in a study published today ...
Jun 15, 2022
0
51
Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).
Dec 6, 2023
0
110
The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell clusters known as tertiary lymphoid structures (TLS), according to researchers ...
Jan 15, 2020
0
297
Published in Nature Aging, University of Minnesota Medical School researchers have provided new insight into enhancing immune responses in older individuals and the potential for using immunotherapy to make older adults less ...
May 15, 2024
0
56
Mount Sinai researchers have developed a way to use immunotherapy drugs against treatment-resistant non-Hodgkin's lymphomas for the first time by combining them with stem cell transplantation, an approach that also dramatically ...
Aug 2, 2019
0
1
A new study led by investigators from Brigham and Women's Hospital in collaboration with colleagues at the Broad Institute examines the effects of checkpoint blockade therapies on different populations of T cells, a key class ...
Jan 8, 2019
0
72
A new study by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC—James) suggests a way to re-energize critical killer ...
Jan 24, 2023
0
54
New research from a collaborative team at Cleveland Clinic, led by Timothy Chan, MD, Ph.D., Chair of the Center for Immunotherapy and Precision Immuno-Oncology in the Lerner Research Institute, is demonstrating that pathogenic ...
Jul 13, 2022
0
53
